Medicrea Announces 510(k) Submission for FDA Clearance of Proprietary 3D Printed Titanium Spinal Interbody Devices 3D Printing Processes
The Medicrea Group, worldwide leader pioneering the development and manufacture of personalized analytical services and implant solutions for the treatment of complex spinal conditions, today announced the filing of its 510(k) submission to the U.S. Food and Drug Administration (FDA) for approval of the Company’s 3D printed titanium interbody devices, with compatible UNiD™ Lab personalized surgical planning and analytical services.